Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Basilard BioTech features a technology platform that transforms the rapidly growing cell-based therapies market.
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Exo Therapeutics is a small molecule drug discovery and development company.
Zentera Therapeutics is a biopharmaceutical company.
Mnemo Therapeutics specializes in biotechnology and life science.
Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Apton Biosystems develops an optical system designed for sequencing and protein detection.
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies
Imagen is a healthcare organization that provides onsite and diagnostic solutions to maximize clinical outcomes and patient satisfaction.
Faze Medicines is a biotechnology company.
PanThera CryoSolutions designs and manufactures cryopreservation solutions for cells, tissues, and organs.
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.
Sexton Biotechnologies is a biotechnology company.
Singular Bio is a privately held company developing single molecule detection technology.
Prominex is focused on the development and manufacture of molecular diagnostic assays for Point-of-Care (POC) infectious disease testing.
NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Casdin Capital has invested in 95 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Casdin Capital's top investment sectors include Biotechnology, Health Care, Medical, Genetics, Therapeutics. The firm invests across 22 different industry categories.
Among tracked funding rounds, 908 Devices received $101.0M in a Post Ipo Equity round. Casdin Capital's total known invested capital is $8.1B.
Casdin Capital's average investment size is $93.1M across its portfolio of 95 companies.
Recent Casdin Capital portfolio additions include InnoSIGN, Creyon Bio, Basilard BioTech, Depixus, Exai Bio. These companies were founded in 2020 or later.